AIDS-related tuberculosis in Rio de Janeiro, Brazil.
BACKGROUND
We studied the incidence of tuberculosis, AIDS, AIDS deaths and AIDS-TB co-infection at the population level in Rio de Janeiro, Brazil where universal and free access to combination antiretroviral therapy has been available since 1997.


RESULTS
This was a retrospective surveillance database match of Rio de Janeiro databases from 1995-2004. Proportions of tuberculosis occurring within 30 days and between 30 days and 1 year after AIDS diagnosis were determined. Generalized additive models fitted with cubic splines with appropriate estimating methods were used to describe rates and proportions over time. Overall, 90,806 tuberculosis cases and 16,891 AIDS cases were reported; 3,125 tuberculosis cases within 1 year of AIDS diagnosis were detected. Tuberculosis notification rates decreased after 1997 from a fitted rate (fR per 100,000) of 166.5 to 138.8 in 2004. AIDS incidence rates increased 26% between 1995 and 1998 (30.7 to 38.7) followed by a 33.3% decrease to 25.8 in 2004. AIDS mortality rates decreased dramatically after antiretroviral therapy was introduced between 1995 (27.5) and 1999 (13.4). The fitted proportion (fP) of patients with tuberculosis diagnosed within one year of AIDS decreased from 1995 (24.4%) to 1998 (15.2%), remaining stable since. Seventy-five percent of tuberculosis diagnoses after an AIDS diagnosis occurred within 30 days of AIDS diagnosis.


CONCLUSIONS
Our results suggest that while combination ART should be considered an essential component of the response to the HIV and HIV/tuberculosis epidemics, it may not be sufficient alone to prevent progression from latent TB to active disease among HIV-infected populations. When tuberculosis is diagnosed prior to or at the same time as AIDS and ART has not yet been initiated, then ART is ineffective as a tuberculosis prevention strategy for these patients. Earlier HIV/AIDS diagnosis and ART initiation may reduce TB incidence in HIV/AIDS patients. More specific interventions will be required if HIV-related tuberculosis incidence is to continue to decline.
Pacheco
Antonio G
AG
ENSP/PROCC, FIOCRUZ, Rio de Janeiro, Brazil.
Durovni
Betina
B
Cavalcante
Solange C
SC
Lauria
L M
LM
Moore
Richard D
RD
Moulton
Lawrence H
LH
Chaisson
Richard E
RE
Golub
Jonathan E
JE
D000163:Acquired Immunodeficiency Syndrome / Q000150:complications* / Q000453:epidemiology* / Q000401:mortality / Q000821:virology; D044966:Anti-Retroviral Agents / Q000494:pharmacology; D000995:Antitubercular Agents / Q000494:pharmacology; D001938:Brazil; D015897:Comorbidity; D004813:Epidemiology; D006801:Humans; D015994:Incidence; D011634:Public Health; D012042:Registries; D012189:Retrospective Studies; D014376:Tuberculosis / Q000150:complications* / Q000453:epidemiology* / Q000821:virology
D044966:Anti-Retroviral Agents; D000995:Antitubercular Agents
AIDS. 2007 Jul 11;21(11):1441-8
17589190
Braz J Infect Dis. 2005 Feb;9(1):9-19
15947842
Int J Tuberc Lung Dis. 2001 Mar;5(3):213-5
11326818
Int J Tuberc Lung Dis. 1999 Jun;3(6):457-65
10383056
Lancet. 2002 Jun 15;359(9323):2059-64
12086758
J Bras Pneumol. 2006 Sep-Oct;32(5):444-8
17268749
Stat Methods Med Res. 1995 Sep;4(3):187-96
8548102
Int J Tuberc Lung Dis. 2000 Nov;4(11):1026-31
11092714
Clin Infect Dis. 2002 Feb 15;34(4):543-6
11797184
Science. 2003 Sep 12;301(5639):1535-7
12920302
AIDS. 2000 Sep 8;14(13):1985-91
10997404
PLoS One. 2007 Sep 05;2(9):e826
17786198
Clin Infect Dis. 2007 Jan 1;44(1):94-102
17143823
AIDS. 2003 Jul 25;17(11):1675-82
12853750
Arch Intern Med. 2003 May 12;163(9):1009-21
12742798
AIDS. 2006 Aug 1;20(12):1605-12
16868441